Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05052268
Title XTX202 in Patients With Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Xilio Development, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UC San Diego Moores Cancer Center La Jolla California 92093 United States Details
Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
University of California Los Angeles Los Angeles California 90095 United States Details
Hoag Memorial Hospital Presbyterian- Newport Beach Newport Beach California 92663 United States Details
Georgetown University Medical Center Washington District of Columbia 20007 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
University of Iowa Hospitals and Clinics Iowa City Iowa 52242 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
HealthPartners Cancer Center at Regions Hospital Saint Paul Minnesota 55101 United States Details
Atlantic Health System/Morristown Medical Center Morristown New Jersey 07960 United States Details
Rutgers Cancer Institute of NJ New Brunswick New Jersey 08903 United States Details
Carolina BioOncology Institute Huntersville North Carolina 28078 United States Details
The Ohio State University Wexner Medical Center James Cancer Hospital and Solove Research Institute Columbus Ohio 43210 United States Details
UPMC Hillman Cancer Center Pavilion Pittsburgh Pennsylvania 15213 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field